Shukra Pharmaceuticals Clarifies Share Price Movement is Purely Market-Driven
Shukra Pharmaceuticals Ltd 路 Others (Uncategorized) 路 07 Oct 2026, 12:01 am
Shukra Pharmaceuticals Clarifies Share Price Movement is Purely Market-Driven Shukra Pharmaceuticals Ltd clarified to BSE on 6th Oct'26 that recent movements in its share price are purely market-driven by natural forces, with management having no connection to the volatility. The company confirmed full compliance with SEBI LODR Regulation 30, stating that all material events, operations, and corporate actions have been disclosed timely. Additionally, the company affirmed there is no pending announcement or undisclosed price-sensitive information requiring investor disclosure at this stage.
Original exchange filing (PDF)
More announcements from Shukra Pharmaceuticals Ltd
- Approval for Change of Name of Company on National Stock Exchange Limited dated 16th November 2026 路 17 Nov 2026
- Media Release 路 05 Nov 2026
- Shukra Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Reg 32 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- SHUKRA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 04 Nov 2026
- The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 路 04 Nov 2026
